about
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversityCeftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic modelAntimicrobials therapy of anaerobic infections.Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo.How antibiotics kill bacteria: new models needed?Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik's Cube of Clinical Microbiology?Infection, antibiotic therapy and risk of colorectal cancer: a nationwide nested case-control study in patients with Type 2 diabetes mellitus.
P2860
Q37256108-2259DDD7-4F56-462D-B579-2C3319C649DDQ37544518-3851729F-4772-4F18-A736-D9DE61234D40Q38586018-DAA10654-F9D7-4FB3-AB58-0240B4B89F2EQ38659649-8CB3AB57-EAC7-4E9F-842F-9D240466D707Q42263892-3CAA2F56-41C5-4DBD-9427-91045C1BE80AQ46266852-F96D0475-359A-4CD8-8DF2-05A86AA9D2E4Q51118909-45FD5B2E-6798-4171-B19C-18BA8966123C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antimicrobial treatment of anaerobic infections.
@en
Antimicrobial treatment of anaerobic infections.
@nl
type
label
Antimicrobial treatment of anaerobic infections.
@en
Antimicrobial treatment of anaerobic infections.
@nl
prefLabel
Antimicrobial treatment of anaerobic infections.
@en
Antimicrobial treatment of anaerobic infections.
@nl
P2860
P1476
Antimicrobial treatment of anaerobic infections.
@en
P2093
Itzhak Brook
P2860
P304
P356
10.1517/14656566.2011.576672
P407
P577
2011-04-21T00:00:00Z